RNDr. Jan Škoda, Ph.D.
Assistant professor, Section of Genetics and Molecular Biology
Office: bldg. C13/326
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8021 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 38
2024
-
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease
Cellular and Molecular Biology Letters, year: 2024, volume: 29, edition: 1, DOI
2023
-
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
Cell Death and Disease, year: 2023, volume: 14, edition: 11, DOI
2022
-
Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment
Cancers, year: 2022, volume: 14, edition: 24, DOI
-
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 1, DOI
-
Noncanonical roles of p53 in cancer stemness and their implications in sarcomas
Cancer letters, year: 2022, volume: 525, edition: January, DOI
-
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
EMBO Journal, year: 2022, volume: 41, edition: 8, DOI
-
Serotonin limits generation of chromaffin cells during adrenal organ development
Nature Communications, year: 2022, volume: 13, edition: 1, DOI
-
The Biomania Student Scientific Meeting 2022. Book of Abstracts
Year: 2022, type: Editorship of scientific publication
-
Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
Frontiers in Pharmacology, year: 2022, volume: 13, edition: September, DOI
-
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 15, DOI